NEC OncoImmunity NEC OncoImmunity is a bioinformatics company offering machine learning-based software for the prediction of bona fide immunogenic neoantigens for personalized cancer immunotherapy. | |||||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 2017 | Founding Date 2007 | Founding Date 1997 |
Type | Type Private | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Oxford, GB HQ Singapore, SG Milton, GB Boston, US | Locations Oslo, NO HQ | Locations South San Francisco, US HQ | Locations Tres Cantos, ES HQ | Locations Laval, CA HQ |
Employees | Employees 363% increase | Employees 432% increase | Employees 306% decrease | Employees 28 | Employees 20 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 12m (over 8 years ago) | Latest funding round $ 9.4m (about 14 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 2.5m | Total funding raised $ 12m | Total funding raised $ 9.4m | Total funding raised N/A |
NEC OncoImmunity is a bioinformatics company offering machine learning-based software for the prediction of bona fide immunogenic neoantigens for personalized cancer immunotherapy.
View company
3T Biosciences is an immunotherapy company.
View company
Vivia Biotech is a company specializing in providing individualized medicine.
View company